These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 944093)

  • 21. Interaction of antileukemia agents adriamycin and daunomycin with sphinganine on the differentiation of human leukemia cell line HL-60.
    Yung BY; Luo KJ; Hui EK
    Cancer Res; 1992 Jul; 52(13):3593-7. PubMed ID: 1617630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of adriamycin and daunomycin on spleen cell populations in normal and tumor allografted mice.
    Mantovani A; Tagliabue A; Vecchi A; Spreafico F
    Eur J Cancer (1965); 1976 May; 12(5):381-7. PubMed ID: 1085252
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on the immuno-suppressive effects of adriamycin and tumor metastasis (author's transl)].
    Chang S; Toida S; Abe M; Hayashi M
    Nihon Seikeigeka Gakkai Zasshi; 1980 Jul; 54(7):677-84. PubMed ID: 7009766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive effect of mouse serum lipoproteins. II. In vivo studies.
    Hsu KH; Hiramoto RN; Ghanta VK
    J Immunol; 1982 May; 128(5):2107-10. PubMed ID: 7037961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment.
    Tomazic V; Ehrke MJ; Mihich E
    Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunosuppressive activity of Fusarium toxins. Effects on antibody synthesis and skin grafts of crude extracts, T2-toxin and diacetoxyscirpenol.
    Rosenstein Y; Lafarge-Frayssinet C; Lespinats G; Loisillier F; Lafont P; Frayssinet C
    Immunology; 1979 Jan; 36(1):111-7. PubMed ID: 369993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Augmentation of immunologic memory in mice following treatment with oxisuran.
    Fox AE; Freedman HH
    J Immunol; 1974 Apr; 112(4):1394-400. PubMed ID: 4592600
    [No Abstract]   [Full Text] [Related]  

  • 28. Chymopapain C: an immunosuppressive protease. II. Effect on the primary and secondary immune response of mice.
    Clagett JA; Tokuda S; Engelhard WE
    J Immunol; 1974 May; 112(5):1660-6. PubMed ID: 4594413
    [No Abstract]   [Full Text] [Related]  

  • 29. [Action of doxorubicin on immunogenesis].
    Shapovalova SP; Malkova IV
    Antibiotiki; 1983 Apr; 28(4):304-7. PubMed ID: 6344783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression.
    Schwartz HS; Grindey GB
    Cancer Res; 1973 Aug; 33(8):1837-44. PubMed ID: 4720795
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunodepressive activity of FCE 23762 on humoral and cell-mediated immune responses in normal mice: comparison with doxorubicin.
    Fornasiero MC; Ferrari M; Gnocchi P; Trizio D; Isetta AM
    Agents Actions; 1992 Nov; 37(3-4):311-8. PubMed ID: 1295379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunosubversive role of PGE2 in tumor bearing mice.
    Ippoliti F; Sezzi ML; Bellelli L; Naso G; Pontieri GM
    Boll Ist Sieroter Milan; 1985; 64(1):25-34. PubMed ID: 3859302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Defects in cell-mediated and humoral immunity in tumor-bearing mice. Evidence and characterization of suppressor cells ].
    Siegl E; Günther J; Schulze HA; Brock J
    Allerg Immunol (Leipz); 1981; 27(3):153-61. PubMed ID: 6214936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
    Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
    Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: studies on cell-mediated immunity and humoral antibody response.
    Mantovani A; Spreafico F
    Eur J Cancer (1965); 1975 Aug; 11(8):537-44. PubMed ID: 1222761
    [No Abstract]   [Full Text] [Related]  

  • 36. Differential effects of 5-fluorouracil analogs on humoral and cell-mediated responses in mice: augmentation of delayed hypersensitivity response against picryl chloride by 1,3-bis(tetrahydro-2-furanyl)-5-fluoro-2,4-pyrimidinedione (FD-1), a new anti-tumor drug.
    Yamada Y; Miyauchi S; Unemi N
    J Clin Lab Immunol; 1980 Nov; 4(3):153-7. PubMed ID: 6451710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis and reversal of the inhibition of cytophilic antibody receptors produced by antibody.
    Mitchell MS; Mokyr MB; Goldwater DJ
    Cancer Res; 1975 May; 35(5):1121-7. PubMed ID: 1078991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of lactoferrin on the methotrexate-induced suppression of the cellular and humoral immune response in mice.
    Artym J; Zimecki M; Kruzel ML
    Anticancer Res; 2004; 24(6):3831-6. PubMed ID: 15736418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of host-dependent high-grade tumor-specific immunity through a novel mechanism triggered by the Lyt-2+ tumor-specific T cell clone (K7L) that induces temporal growth of L1210 leukemia-K7L-variant.
    Nagase F; Ueda K; Kawashima K; Jamshedur Rahman SM; Isobe K; Yoshida T; Hasegawa Y; Ando K; Iwamoto T; Nagura E
    J Immunol; 1987 Apr; 138(7):2359-65. PubMed ID: 2951438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.